Cargando…

Modulated anti-VEGF therapy under the influence of lipid metabolizing proteins in Age related macular degeneration: a pilot study

Age-related macular degeneration (AMD) is a devastating retinal disease that results in irreversible vision loss in the aged population. The complex genetic nature and degree of genetic penetrance require a redefinition of the current therapeutic strategy for AMD. We aimed to investigate the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Kaushal, Battu, Priya, Singh, Ramandeep, Sharma, Suresh Kumar, Anand, Akshay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758686/ https://www.ncbi.nlm.nih.gov/pubmed/35027571 http://dx.doi.org/10.1038/s41598-021-04269-6

Ejemplares similares

Genotyping of Clinical Parameters in Age-Related Macular Degeneration
por: Battu, Priya, et al.
Publicado: (2022)

Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015)

Superoxide Dismutase1 Levels in North Indian Population with Age-Related Macular Degeneration
por: Anand, Akshay, et al.
Publicado: (2013)

Sleeping pattern and activities of daily living modulate protein expression in AMD
por: Sharma, Kaushal, et al.
Publicado: (2021)

Association between CFH Y402H Polymorphism and Age Related Macular Degeneration in North Indian Cohort
por: Sharma, Neel Kamal, et al.
Publicado: (2013)

Single Nucleotide Polymorphisms in MCP-1 and Its Receptor Are Associated with the Risk of Age Related Macular Degeneration
por: Anand, Akshay, et al.
Publicado: (2012)

Using Current Data to Define New Approach in Age Related Macular Degeneration: Need to Accelerate Translational Research
por: Anand, Akshay, et al.
Publicado: (2014)

CCL2 single nucleotide polymorphism of rs1024611 implicates prominence of inflammatory cascade by univariate modeling in Indian AMD
por: Sharma, Neel Kamal, et al.
Publicado: (2018)

AMD Genetics in India: The Missing Links
por: Anand, Akshay, et al.
Publicado: (2016)

New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2012)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)

Application and mechanism of anti-VEGF drugs in age-related macular degeneration
por: Song, Dawei, et al.
Publicado: (2022)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
por: Balikova, Irina, et al.
Publicado: (2019)

Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
por: Senra, Hugo, et al.
Publicado: (2016)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021)

Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment
por: Oca, Ana I., et al.
Publicado: (2021)

Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
por: Giancipoli, Ermete, et al.
Publicado: (2018)

Management of Type II Diabetes by Modulating the Modifiable Risk Factors: A Future Roadmap for Prevention of Cerebrovascular Complications
por: Sharma, Kanupriya, et al.
Publicado: (2021)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
por: Kabanarou, Stamatina A, et al.
Publicado: (2017)

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
por: Hussain, Rehan M., et al.
Publicado: (2021)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
por: Isildak, Hacer, et al.
Publicado: (2018)

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
por: Pfau, Maximilian, et al.
Publicado: (2021)

Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
por: Ozdemir, Semra, et al.
Publicado: (2022)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration
por: Jain, Sachin, et al.
Publicado: (2013)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Changes in neurophysiologic markers of visual processing following beneficial anti-VEGF treatment in macular degeneration
por: Vottonen, Pasi, et al.
Publicado: (2013)

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
por: Yang, Shiqi, et al.
Publicado: (2016)

Effect of anti-VEGF drugs combined with photodynamic therapy in the treatment of age-related macular degeneration
por: Dong, Yi, et al.
Publicado: (2016)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
por: Miyamoto, Noriko, et al.
Publicado: (2017)

Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration
por: Strunz, Tobias, et al.
Publicado: (2022)

Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes
por: William, Antony, et al.
Publicado: (2023)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
por: Hirata, Akira, et al.
Publicado: (2017)

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
por: Garweg, Justus G., et al.
Publicado: (2021)

Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis
por: Li, Songshan, et al.
Publicado: (2017)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)

Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
por: Arai, Yusuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tnbsnt8rju9gt6coh736bqdtoc